| scholarly article | Q13442814 |
| P50 | author | Monina Klevens | Q91805742 |
| Ruth Jiles | Q115103255 | ||
| Scott D Holmberg | Q115103261 | ||
| P2093 | author name string | Dale J Hu | |
| P2860 | cites work | A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs | Q24629455 |
| Factors Associated with Prevalent Hepatitis C Infection Among HIV-Infected Women with No Reported History of Injection Drug Use: The Women's Interagency HIV Study (WIHS) | Q27490928 | ||
| Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Natural history of chronic hepatitis C | Q29620673 | ||
| Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials | Q30500804 | ||
| Population-based surveillance for hepatitis C virus, United States, 2006-2007 | Q33644558 | ||
| Is sexual contact a major mode of hepatitis C virus transmission? | Q34126319 | ||
| Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men | Q34663297 | ||
| Changes in blood-borne infection risk among injection drug users | Q34772870 | ||
| Sexual activity as a risk factor for hepatitis C. | Q34984066 | ||
| People with multiple tattoos and/or piercings are not at increased risk for HBV or HCV in The Netherlands. | Q35213999 | ||
| Transmission of hepatitis C virus infection through tattooing and piercing: a critical review | Q36185545 | ||
| Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. | Q36440948 | ||
| Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. | Q36505814 | ||
| Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. | Q37362857 | ||
| Hepatitis C virus transmission at an outpatient hemodialysis unit--New York, 2001-2008. | Q37407808 | ||
| Molecular epidemiology of health care-associated transmission of hepatitis B and C viruses | Q37685600 | ||
| Insulin resistance, hepatic steatosis and hepatitis C: a complex relationship with relevant clinical implications. | Q37780410 | ||
| Manifestations of chronic hepatitis C virus infection beyond the liver | Q37792523 | ||
| A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel | Q37886280 | ||
| Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update | Q38020159 | ||
| Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). | Q39551426 | ||
| Chronic liver disease after acute non-A, non-B viral hepatitis | Q39693936 | ||
| Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours | Q39795088 | ||
| The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. | Q39883472 | ||
| Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use. | Q42635260 | ||
| Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities | Q42644890 | ||
| Tattoos, incarceration and hepatitis B and C among street-recruited injection drug users in New Mexico, USA: update | Q42672932 | ||
| Prevalence and incidence of hepatitis C virus infection among young adult injection drug users | Q42680870 | ||
| Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. | Q42978282 | ||
| Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection | Q42997283 | ||
| Hepatitis C virus infections from unsafe injection practices at an endoscopy clinic in Las Vegas, Nevada, 2007-2008. | Q42997957 | ||
| Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States | Q42998939 | ||
| Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men--New York City, 2005-2010. | Q43038865 | ||
| Hepatitis C virus seroconversion among young injection drug users: relationships and risks | Q43041146 | ||
| Notes from the field: risk factors for hepatitis C virus infections among young adults--Massachusetts, 2010. | Q43041805 | ||
| Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing | Q44277007 | ||
| The importance of preventing hepatitis C virus infection among injection drug users in the United States. | Q44458986 | ||
| Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough | Q44644731 | ||
| The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. | Q44979610 | ||
| Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. | Q45202964 | ||
| National surveillance of dialysis-associated diseases in the United States, 2002. | Q45233196 | ||
| Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007. | Q45395054 | ||
| Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. | Q45423068 | ||
| Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. | Q50169211 | ||
| Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians. | Q53516428 | ||
| Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. | Q55240560 | ||
| Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006 | Q64128835 | ||
| The epidemiological pattern of hepatitis A, B, and non-A, non-B in Sweden | Q67423930 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| epidemiology | Q133805 | ||
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | S3-9 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Evolving epidemiology of hepatitis C virus in the United States | |
| P478 | volume | 55 Suppl 1 |
| Q40536482 | "Hep C, where art thou": What are the remaining (fundable) questions in hepatitis C virus research? |
| Q36959607 | 30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs |
| Q57825993 | A Population-Based Surveillance Study on the Epidemiology of Hepatitis C in Estonia |
| Q33447050 | A Smartphone Application Supporting Recovery from Heroin Addiction: Perspectives of Patients and Providers in China, Taiwan, and the USA |
| Q47607535 | An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots |
| Q93085314 | Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices |
| Q39602767 | Antibody Response to Hypervariable Region 1 Interferes with Broadly Neutralizing Antibodies to Hepatitis C Virus |
| Q36233117 | Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C. |
| Q87406414 | Assessment of hepatitis C risk factors and infection prevalence in a jail population |
| Q37455559 | Association between prescription drug misuse and injection among runaway and homeless youth |
| Q35864200 | Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users |
| Q34971493 | Associations between prescription opioid injection and Hepatitis C virus among young injection drug users |
| Q42270225 | Birth cohort testing for hepatitis C virus: implications for clinical social workers in health care settings |
| Q30234676 | Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review |
| Q58789402 | Case Report: Patient with Hepatitis C, p-ANCA, and Cryoglobulin Antibodies Presenting with Necrotizing Crescentic p-ANCA Glomerulonephritis |
| Q90106891 | Characterization of the hepatitis C virus epidemic in Pakistan |
| Q40588090 | Chronic hepatitis C virus (HCV) burden in Rhode Island: modelling treatment scale-up and elimination |
| Q31143582 | Comparative treatment effectiveness of direct acting antiviral regimens for hepatitis C: Data from the Veterans administration |
| Q35935659 | Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus |
| Q51847014 | Confronting the emerging epidemic of HCV infection among young injection drug users. |
| Q41261310 | Contextual analysis of determinants of late diagnosis of hepatitis C virus infection in medicare patients |
| Q40194957 | Contrasting HCV and HIV seroepidemiology in 11 years of blood donors screening in Brazil. |
| Q40716735 | Coverage for hepatitis C drugs in Medicare Part D. |
| Q89718158 | Discontinuation of new hepatitis C drugs among Medicare patients |
| Q59357649 | Enhanced identification of maternal hepatitis C virus infection using existing public health surveillance systems |
| Q93115310 | Epidemiology of Hepatitis C |
| Q26750444 | Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region |
| Q35865346 | Epidemiology of hepatitis C virus infection among people receiving opioid substitution therapy (ECHO): study protocol |
| Q51852529 | Estimating acute viral hepatitis infections from nationally reported cases. |
| Q35147007 | Estimating the true prevalence of hepatitis C in rhode island |
| Q92895147 | Foot drop with a popliteal artery aneurysm due to heroin use: A case report |
| Q37617937 | Gender specific medicine in liver diseases: a point of view |
| Q38840669 | Geographic Disparities in Access to Syringe Services Programs Among Young Persons With Hepatitis C Virus Infection in the United States |
| Q91843571 | HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco |
| Q89184080 | HIV/HCV Co-infection: Burden of Disease and Care Strategies in Appalachia |
| Q28084654 | Hepatitis C |
| Q36504911 | Hepatitis C Infection Among Hispanics in California |
| Q46288266 | Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations |
| Q57468086 | Hepatitis C Virus-Infected Apoptotic Hepatocytes Program Macrophages and Hepatic Stellate Cells for Liver Inflammation and Fibrosis Development: Role of Ethanol as a Second Hit |
| Q33578932 | Hepatitis C among blood donors: cascade of care and predictors of loss to follow-up. |
| Q54226744 | Hepatitis C in Pregnancy. |
| Q57162382 | Hepatitis C virus genotype 3: clinical features, current and emerging viral inhibitors, future challenges |
| Q36482820 | Hepatitis C virus in American Indian/Alaskan Native and Aboriginal peoples of North America |
| Q37237054 | Hepatitis C virus in Mexican Americans: a population-based study reveals relatively high prevalence and negative association with diabetes |
| Q36466354 | Hepatitis C virus seroprevalence in pregnant women delivering live-born infants in North Thames, England in 2012. |
| Q38166700 | Hepatitis C virus: an overview for dental health care providers |
| Q43037791 | Hepatitis C virus: the 25-year journey from discovery to cure |
| Q38635796 | Hepatitis C: Review of the Epidemiology, Clinical Care, and Continued Challenges in the Direct Acting Antiviral Era. |
| Q40082158 | High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic |
| Q38736362 | Hospitalizations for Endocarditis and Associated Health Care Costs Among Persons with Diagnosed Drug Dependence - North Carolina, 2010-2015. |
| Q33840260 | Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines |
| Q46597840 | Impact of moderate alcohol discontinuation on insulin action and secretion in Latinos with and without hepatitis C. |
| Q36858894 | Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014. |
| Q88968126 | Improving adherence to hepatitis C screening guidelines |
| Q28540278 | Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period |
| Q38767676 | Kushenin induces the apoptosis of HCV-infected cells by blocking the PI3K-Akt-mTOR pathway via inhibiting NS5A. |
| Q36052231 | Ledipasvir/Sofosbuvir. |
| Q64966688 | Management of opioid use disorder in the USA: present status and future directions. |
| Q64126166 | National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment |
| Q34354269 | National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States |
| Q36127059 | New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison |
| Q45326933 | Non-medical use of prescription opioids is associated with heroin initiation among US veterans. |
| Q38117549 | Novel therapies for hepatitis C - one pill fits all? |
| Q22809427 | Pathogenesis of hepatitis C during pregnancy and childhood |
| Q57152417 | Patterns in Liver-Related Health Outcomes with Hepatitis C Virus Treatments and Health Equity Implications for Decision Makers: A Cohort Analysis of Medicaid Patients |
| Q38208100 | Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity |
| Q40049914 | Population-level intervention and information collection in dynamic healthcare policy. |
| Q42282016 | Potential P-glycoprotein pharmacokinetic interaction of telaprevir with morphine or methadone |
| Q47590769 | Prevalence of Hepatitis C Screening, Testing, and Care Experience Among Young Adults Who Use Prescription Opioids Nonmedically. |
| Q57212757 | Prevalence of Viral Hepatitis in Foreign-Born Populations in the Baltimore-Washington Metropolitan Area, 2009-2015 |
| Q35746376 | Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided Therapy |
| Q41926596 | Recovery of Infectious Hepatitis C Virus from Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs |
| Q40317993 | Retention in buprenorphine treatment is associated with improved HCV care outcomes |
| Q90436425 | Rising Trends in Emergency Department Visits Associated With Hepatitis C Virus Infection in the United States, 2006-2014 |
| Q36021369 | Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study |
| Q51816433 | Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. |
| Q33707925 | Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention |
| Q38407722 | Ritonavir-boosted protease inhibitor based therapy: a new strategy in chronic hepatitis C therapy |
| Q37597763 | Role of IL28-B Polymorphism (rs12979860) on Sustained Virological Response to Pegylated Interferon/Ribavirin in Iranian Patients With Chronic Hepatitis C. |
| Q37606755 | Single nucleotide polymorphisms of toll-like receptor 7 and toll-like receptor 9 in hepatitis C virus infection patients from central China |
| Q34824904 | Sociodemographic characteristics, knowledge and prevalence of viral hepatitis infection among Vietnamese Americans at community screenings. |
| Q38785530 | Sofosbuvir Monotherapy for Asymptomatic and Noncirrhotic Hepatitis C Infection in a Renal Retransplantation Recipient: A Case Report |
| Q37052393 | Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy |
| Q26784519 | The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysis |
| Q28533642 | Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007 |
| Q36514676 | Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart review |
| Q42208893 | Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009. |
| Q47574660 | Use of injected heroin and risk of hepatitis C in three cities in Colombia |
| Q42991166 | Validation of a solid-phase electrochemical array for genotyping hepatitis C virus. |
| Q34263352 | Vertical transmission of hepatitis C virus: Current knowledge and perspectives |
| Q27025926 | Viral hepatitis C gets personal--the value of human genomics to public health |
| Q34781537 | Will there be a vaccine to prevent HCV infection? |
| Q57301080 | hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents |
Search more.